138 related articles for article (PubMed ID: 15055161)
1. Post-transfusion acute graft versus host disease in a 17-year-old girl with a malignant mesenchymal tumor--report of a case.
Utkan G; Buyukcelik A; Demir O; Sanli H; Pamir A
Acta Med Austriaca; 2003; 30(5):138-41. PubMed ID: 15055161
[TBL] [Abstract][Full Text] [Related]
2. [A case of graft-versus-host disease following red cell concentrate (MAP-CRC) transfusion].
Nakamoto T; Nishi S; Shindoh M; Hayashi M; Yukioka H; Fujimori M; Maekawa N
Masui; 1995 Sep; 44(9):1261-4. PubMed ID: 8523663
[TBL] [Abstract][Full Text] [Related]
3. A case of sclerodermatous graft-versus-host disease following autologous peripheral blood stem cell transplantation.
Nakamura K; Kawakami Y; Oyama N; Kaneko F; Abe H; Sagara H; Ohto H
J Dermatol; 2006 Feb; 33(2):135-8. PubMed ID: 16556284
[TBL] [Abstract][Full Text] [Related]
4. Prevention of post-transfusion graft-versus-host disease.
Tasaki T; Ohto H; Abe R
Fukushima J Med Sci; 1993 Dec; 39(2):109-11. PubMed ID: 7927133
[TBL] [Abstract][Full Text] [Related]
5. Transfusion-associated graft-vs-host disease. A fatal case caused by blood from an unrelated HLA homozygous donor.
Gorman TE; Julius CJ; Barth RF; Ng A; Kennedy MS; Prior TW; Allen J; Lasky LC
Am J Clin Pathol; 2000 May; 113(5):732-7. PubMed ID: 10800407
[TBL] [Abstract][Full Text] [Related]
6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
7. Transfusion-associated graft-versus-host disease in severe combined immunodeficiency.
Sebnem Kilic S; Kavurt S; Balaban Adim S
J Investig Allergol Clin Immunol; 2010; 20(2):153-6. PubMed ID: 20461970
[TBL] [Abstract][Full Text] [Related]
8. Graft-versus-host disease: case report and review of literature.
Jing X; Halat S; Meleg-Smith S
J La State Med Soc; 2006; 158(1):20-4. PubMed ID: 16602481
[TBL] [Abstract][Full Text] [Related]
9. Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells.
Triulzi D; Duquesnoy R; Nichols L; Clark K; Jukic D; Zeevi A; Meisner D
Transfusion; 2006 Jun; 46(6):885-8. PubMed ID: 16734803
[TBL] [Abstract][Full Text] [Related]
10. Acute graft-versus-host disease of the heart.
Roberts SS; Leeborg N; Loriaux M; Johnson FL; Huang ML; Stenzel P; Thiede C; Godder KT
Pediatr Blood Cancer; 2006 Oct; 47(5):624-8. PubMed ID: 16206193
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of post-transfusion graft-versus-host disease after formalin-fixation.
Ryo R; Goto M; Takada M; Saigo K; Yamaguchi N; Hayashi M; Ito H; Onoyama H; Saito Y; Uchida S
Int J Hematol; 1994 Jun; 59(4):297-302. PubMed ID: 8086623
[TBL] [Abstract][Full Text] [Related]
12. Myeloablative cord blood transplantation for adults with hematological malignancies using tacrolimus and short-term methotrexate for graft-versus-host disease prophylaxis: single-institution analysis.
Yamada MF; Miyamura K; Fujiwara T; Kohata K; Okitsu Y; Ohguchi H; Yamamoto J; Yokoyama H; Tomiya Y; Ishizawa K; Kameoka J; Harigae H
Transplant Proc; 2008 Dec; 40(10):3637-42. PubMed ID: 19100456
[TBL] [Abstract][Full Text] [Related]
13. Acute graft-versus-host disease (GVHD) overlapping chronic GVHD after reinduction chemotherapy.
Delgado-Jimenez Y; Goiriz R; Vargas-Diez E; Fraga J; Garcia-Diez A; Fernandez-Herrera J
Br J Dermatol; 2007 Feb; 156(2):388-90. PubMed ID: 17223891
[No Abstract] [Full Text] [Related]
14. Treatment of acute post-transfusion- graft-versus-host disease (GVHD) with intravenous human immunoglobulins: a case report.
Orlandi C; Frassetto A; Gnucci E; Lehmann JR; Neri R; Melandri D
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):760-1. PubMed ID: 16836524
[No Abstract] [Full Text] [Related]
15. Severe eosinophilia as a manifestation of acute graft-versus-host disease.
Paralkar VR; Goradia A; Luger SM; Loren AW
Oncology; 2008; 75(3-4):134-6. PubMed ID: 18791329
[TBL] [Abstract][Full Text] [Related]
16. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
Lin Q; Dong M; Wang QM; Wen JY; Wu XY
Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772
[TBL] [Abstract][Full Text] [Related]
17. Rapid molecular cytogenetic diagnosis of transfusion associated graft-versus-host disease by fluorescent in situ hybridization (FISH).
Akay MO; Temiz G; Teke HU; Gunduz E; Acikalin MF; Isiksoy S; Durak B; Gulbas Z
Transfus Apher Sci; 2008 Jun; 38(3):189-92. PubMed ID: 18487090
[TBL] [Abstract][Full Text] [Related]
18. Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed hodgkin lymphoma: results of a spanish prospective cooperative protocol.
Alvarez I; Sureda A; Caballero MD; Urbano-Ispizua A; Ribera JM; Canales M; García-Conde J; Sanz G; Arranz R; Bernal MT; de la Serna J; Díez JL; Moraleda JM; Rubió-Félix D; Xicoy B; Martínez C; Mateos MV; Sierra J
Biol Blood Marrow Transplant; 2006 Feb; 12(2):172-83. PubMed ID: 16443515
[TBL] [Abstract][Full Text] [Related]
19. Transfusion-associated graft-versus-host disease: a serious residual risk of blood transfusion.
Higgins MJ; Blackall DP
Curr Hematol Rep; 2005 Nov; 4(6):470-6. PubMed ID: 16232385
[TBL] [Abstract][Full Text] [Related]
20. Transfusion associated graft versus host disease.
Gupta A; Bansal D; Dass R; Das A
Indian Pediatr; 2004 Dec; 41(12):1260-4. PubMed ID: 15623910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
